Gene expression profiling in seminoma and nonseminoma

Journal of Clinical Oncology

Volumn 23, Issue 1, 2005, Pages 58-69

  Port, M ^a   Schmelz, Hans Ulrich ^a   Stockinger, M ^a   Sparwasser, C ^a   Albers, P ^a   Pottek, T ^a   Abend, M ^a  

^a Bundeswehrkrankenhaus Hamburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CANCER GENETICS; CANCER STAGING; CARCINOGENESIS; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SEMINOMA; TECHNIQUE; TUMOR BIOPSY; UPREGULATION; ADOLESCENT; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENETICS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS TUMOR;

ADOLESCENT; ADULT; APOPTOSIS; CELL CYCLE; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEMINOMA; TESTICULAR NEOPLASMS; UP-REGULATION;

EID: 16644384406     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.11.076     Document Type: Article

References (40)

1. Darzynkiewic Z: Apoptosis in antitumor strategies: Modulation of cell cycle or differentiation. J Cell Biochem 58:151-159, 1995
2. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539-542, 1994
3. Isaacs JT: Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr Opin Oncol 6:82-89, 1994
4. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972
5. Lee JM, Bernstein A: Apoptosis, cancer and the p53 tumor suppressor gene. Cancer Metastasis Rev 14:149-161, 1995
6. Rubin LL, Philpott KL, Brooks SF: The cell cycle and cell death. Curr Biol 3:391-394, 1993
7. Abend M, Schmelz HU, Kraft K, et al: Intercomparison of apoptosis morphology with DNA cleavage on single cells in vitro and on testis tumors. J Pathol 185:419-426, 1998
8. Abend M, Schmelz HU, Kraft K, et al: Modified approach for apoptosis detection reveals changes in apoptotic processes in the seminoma-associated tissue. Apoptosis 4:283-290, 1999
9. Bartkova J, Rajpert de Meyts E, Skakkebak NE, et al: D-type cyclins in adult human testis and testicular cancer: Relation to cell type, proliferation, differentiation, and malignancy. J Pathol 187:573-581, 1999
10. Cheville JC, Sebo TJ, Lager DJ, et al: Leydig cell tumor of the testis: A clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol 22:1361-1367, 1998
11. Heiskanen P, Billig H, Toppari J, et al: Apoptotic cell death in the normal and cryptorchid human testis: The effect of human chorionic gonadotropin on testicular cell survival. Pediatr Res 40:351-356, 1996
12. Koji T, Hishikawa Y, Ando H, et al: Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: Involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis. Biol Reprod 64:946-954, 2001
13. Schmelz HU, Abend M, Kraft K, et al: Apoptosis in human embryonal cell carcinoma: Preliminary results. Urol Res 27:368-375, 1999
14. Schmelz HU, Abend M, Kraft K, et al: Fas/Fas ligand system and apoptosis induction in testicular carcinoma. Cancer 95:73-81, 2002
15. Ulbright TM, Orazim A, de Riese W, et al: The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I nonseminomatous germ cell tumors of the testis. Mod Pathol 7:64-68, 1994
16. Lee J, Richburg JH, Younkin S, et al: The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology 138:2081-2088, 1997
17. Schoch C, Kohlmann A, Schnittger S, et al: Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A 99:10008-10013, 2002
18. Kohlmann A, Schoch C, Schnittger S, et al: Neue Methode zur Diagnostik von Leukämien: DNA-Microarray. Dtsch Med Wochenschr 127:2216-2222, 2002
19. Tanaka TS, Jaradat SA, Lim MK, et al: Genome-wide expression profiling of midgestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci U S A 97:9127-9132, 2000
20. Sgroi DC, Teng S, Robinson G, et al: In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 59:5656-5661, 1999
21. DeRisi J, Penland L, Brown PO, et al: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14:457-460, 1996
22. Skotheim RI, Monni O, Mousses S, et al: New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 62:2359-2364, 2002
23. Dieckmann KP, Skakkebaek NE: Carcinoma in situ of the testis: Review of biological and clinical features. Int J Cancer 83:815-822, 1999
24. Laguna MP, Pizzocaro G, Klepp O, et al: EAU Working Group on Oncological Urology: EAU guidelines on testicular cancer. Eur Urol 40:102-110, 2001
25. Stassen T, Port M, Nuyken I, et al: Radiation-induced gene expression in MCF-7 cells. Int J Radiat Biol 79:319-331, 2003
26. Okamoto Y, Ozaki T, Miyazaki K, et al: UbcH10 is the Cancer-related E2 Ubiquitin-conjugating enzyme. Cancer Res 63:4167-4173, 2003
27. Townsley FM, Aristarkhov A, Beck S, et al: Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc Natl Acad Sci U S A 94:2362-2367, 1997
28. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116-5121, 2001
29. Simon R, Radmacher MD, Dobbin K: Design of studies using DNA microarrays. Genet Epidemiol 23:21-36, 2002
30. Simon R: Bioinformatics and whole genome technologies. Technical Report 005. ftp://linus.nci.nih.gov/pub/techreport/TechReport005.pdf
31. Behrens P, Jeske W, Wernert N, et al: Downregulation of clusterin expression in testicular germ cell tumors. Pathobiology 69:19-23, 2001
32. Young M, Lephart ED, McPhaul MJ: Expression of aromatase cytochrome P450 in rat H540 Leydig tumor cells. J Steroid Biochem Mol Biol 63:37-44, 1997
33. Ogawa T, Poncelet DA, Kinoshita Y, et al: Enhanced expression in seminoma of human zinc finger genes located on chromosome 19. Cancer Genet Cytogenet 100:36-42, 1998
34. Ashwell JD, Berger NA, Cidlowski JA, et al: Coming to terms with death: Apoptosis in cancer and immune development. Immunol Today 15:147-151, 1994
35. Czader M, Mazur J, Pettersson M, et al: Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas. Cancer 77:1180-1188, 1996
36. Wheeler JA, Stephens LC, Tornos C, et al: ASTRO research fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int J Radiat Oncol Biol Phys 32:1487-1493, 1995
37. Heidenreich A, Kuczyk M, Albers P: Molecular pathogenesis and prognostic factors in testicular tumor. Urologe A 37:593-608, 1998
38. Meyn RE, Strasfeld L, Allen C: Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int J Radiat Biol 66:141-149, 1994 (suppl 6)
39. Looijenga LH, Oosterhuis JW: Pathogenesis of testicular germ cell tumors. Rev Reprod 4:90-100, 1999
40. Skakkebaek NE, Berthelsen JG, Giwercman A, et al: Carcinoma in situ of the testis: Possible origin from gonocytes and precursor of all types of germ cell tumors except spermatocytoma. Int J Androl 10:19-28, 1987